Newborn Jaundice PP

Newborn Jaundice

Concept of Jaundice

  • Definition: Jaundice is a common and often temporary condition characterized by an elevation of serum bilirubin.

  • Physiological vs. Pathological Jaundice:

    • Physiological jaundice occurs due to normal processes; pathological jaundice indicates underlying health issues.

  • Bilirubin: A substance derived from the breakdown of red blood cells (RBCs). The liver is underdeveloped in newborns, making it hard to eliminate bilirubin.

  • Symptoms: Yellow pigmentation appears first in the head (sclera and mucous membranes) and progresses to the thorax, abdomen, and extremities.

Extravascular Pathway for RBC Destruction

  • Key organs: Liver, Bone Marrow, and Spleen.

    • Process:

      • RBCs phagocytized and lysed.

      • Hemoglobin is broken down into glucose, amino acids, iron (Fe2+), and bilirubin.

      • Amino acids and iron are recycled; bilirubin is excreted.

Hyperbilirubinemia

  • Definition: Occurs when elevated bilirubin levels are present in the blood, which can be challenging for newborns to eliminate.

  • Consequences: Bilirubin builds up in blood, tissues, and fluids.

  • Excretion Mechanism: Bilirubin is excreted in urine and stools.

  • Importance of Hydration: Vital for the elimination of bilirubin; dehydration exacerbates jaundice.

Risk Factors for Jaundice

  • Increased RBC breakdown or production.

  • Maternal Factors: Negative Rh factor, ABO incompatibility (Mother type O, Infant A, B, or AB).

  • Other factors include:

    • Birth trauma, Anoxia, Prematurity, Induction methods (Oxytocin), infections, Hypoglycemia, Maternal diabetes, and family history of jaundice.

    • Ineffective breastfeeding and decreased liver function also contribute.

Physiological Jaundice

  • Characteristics:

    • Commonly benign, observed in 40% of full-term infants.

    • Results from increased bilirubin production, shortened lifespan, and breakdown of RBCs.

    • Normal biological response of newborns, peaking by the second or third day, typically resolves in 5 to 10 days.

    • Factors influencing bilirubin levels include bruising, feeding patterns, and gastrointestinal activity.

Pathological Jaundice

  • Definition: Indicates an underlying illness or disease.

  • Timing: Can present before 24 hours post-birth or persist beyond 14 days.

  • Symptoms: Rapid increases in bilirubin; often associated with anemia or hepatosplenomegaly.

  • Potential Causes: Infection/sepsis, blood group incompatibility, RBC disorders.

Acute Bilirubin Encephalopathy

  • Description: A neuro syndrome resulting from bilirubin deposits in brain cells.

  • Dangerous Levels: Occurs at bilirubin levels exceeding 25 mg/dl; may cause severe cognitive impairments and movement disorders.

  • Clinical Manifestations: Lethargy, poor feeding, abnormal tone, high-pitched cry, arching of body, and fever.

Kernicterus

  • Definition: A chronic, irreversible condition resulting from bilirubin toxicity.

  • Symptoms mimic those of encephalopathy but may also include hypotonia, severe cognitive impairments, and spastic quadriplegia.

Breastfeeding & Breast Milk Jaundice

  • Breastfeeding Jaundice: Rare; bilirubin levels can rise after the first week due to dehydration from poor feeding.

  • Breast Milk Jaundice: May result from high concentrations of certain fatty acids in milk, enhancing bilirubin circulation, often seen in infants aged 2-3 weeks.

  • Management: Temporary cessation of breastfeeding may be necessary if bilirubin exceeds 20 mg/dl.

Nursing Assessment for Jaundice

  • Detection: First noticeable on the face/mucous membranes/sclera, progressing head-to-toe.

  • Testing: Blanching methods on the nose, forehead, and sternum; appropriate lighting crucial for visibility.

  • Reporting: Any signs before 24 hours must be immediately reported.

  • Complications: Be aware of potential hypoxia, hypothermia, hypoglycemia, and metabolic acidosis following hyperbilirubinemia.

Nursing Care

  • Monitoring: Assess skin, vital signs, and bilirubin levels every 4 hours until normal levels (under 5-6 mg/dl).

  • Temperature Check: Axillary temperatures every 4 hours.

  • Intake and Output: Keep records of feeding, stool production, and daily weights.

  • Adequate Care: Ensure hydration through regular feeds (q 2-3 hours), use lactation consultants if needed, and educate parents about treatments and stool changes.

Phototherapy

  • Setup: Use eye protection for newborns, keep them undressed except for a diaper.

  • Baseline Monitoring: Track vital signs and avoid lotions/ointments to prevent burns.

  • Frequency: Remove newborn from therapy every 4 hours for inspections; observe for skin inflammation.

  • Encouragement: Frequent feeding to combat dehydration; reposition every 2 hours to prevent skin breakdown.

  • Lab Draws: Turn off bilirubin lights before drawing labs.

Observations During Phototherapy

  • Monitoring for Effects: Look for skin discoloration or rashes (not serious), pressure sores, signs of dehydration, temperature fluctuations.

  • Parental Interaction: Encourage parents to hold and interact with the newborn when phototherapy lights are off; bilirubin levels should decrease within 4-6 hours of treatment.

Nursing Care and Follow-up

  • Transcutaneous Bilirubin Meter: A noninvasive tool to measure bilirubin levels.

  • Phototherapy Options: Can be administered at home if warranted.

Discharge Instructions

  • Follow-Up: Schedule within 1-2 days post-discharge.

  • Feeding: Encourage frequent feedings to promote bilirubin excretion.

  • Signs to Report: Advise parents to call if the baby feeds less, appears sleepier or difficult to wake, produces fewer wet diapers, or if there is noticeable yellowing extending below the belly button.

robot